Research has also linked low glutathione to increased risk of chronic conditions including diabetes, hypertension, and certain liver diseases
These effects are typically temporary and subside with continued use
GLP-1 receptor agonists and GIP/GLP-1 dual agonists carry a deep trial record: STEP studied semaglutide for weight management (NEJM 2021), SURMOUNT studied tirzepatide for weight management (NEJM 2022), and SURMOUNT-OSA studied tirzepatide for obstructive sleep apnea (NEJM 2024)
Soluble fiber unlike insoluble fiber, which remains unchanged during digestion attracts water during digestion and turns into a gel
Acetyl-L-carnitine and KET are non-selective, clinical glutamate modulators which have been shown to improve pain and depressed mood in different experimental and clinical settings
Sure, weve all been there